Insight

Apogem Capital gathers $614m for sixth secondary fund

The fund's limited partners include single family offices and pension funds, as well as many existing investors from the firm's prior secondary funds.

-
  • Apogem Capital is a subsidiary of New York Life Insurance Company
  • Apogem Capital was formed in April 2022 through the combination of PA Capital, Madison Capital Funding and GoldPoint Partners
  • Apogen has approximately $39 billion in assets under management as of March 31, 2022

Apogem Capital has closed its sixth secondary fund at about $614 million, beating its $500 million target.

The fund’s limited partners include single family offices and pension funds, as well as many existing investors from the firm’s prior secondary funds.

“We believe our leadership position in the middle market is even stronger following the closing of the merger with PA Capital, Madison Capital and GoldPoint Partners,” said Michael Zeleniuch, managing director at Apogem Capital, in a statement. “We offer innovative and timely solutions to LPs and GPs and believe our PASF VI program1, which represents almost $900 million in committed capital, has never been more relevant. The addressable universe of middle market LP and GP secondaries that we pursue continues to grow, and we feel we are exceptionally well positioned given our multi-decade history in the space.”

Apogem Capital was formed in April 2022 through the combination of PA Capital, Madison Capital Funding and GoldPoint Partners to create a singular and unified, world class private markets’ investment firm. Apogen has approximately $39 billion in assets under management as of March 31, 2022.

Apogem Capital is a subsidiary of New York Life Insurance Company.